Topic: Clade 1

Dr. Peter McCullough claims that the current strain of bird flu originated from serial passage research at a USDA laboratory in Athens, Georgia. McCullough cites a peer-reviewed paper suggesting the virus was engineered to transmit easily among migratory birds and mammals. He recommends Relenza as a potential prophylactic treatment for influenza-type diseases.

The World Health Organization (WHO) has declared a public health emergency of international concern regarding the Clade 1 variant of Mpox originating in the Democratic Republic of Congo. This classification allows for the emergency licensing and distribution of vaccines without standard long-term testing. The variant is described as more contagious than the 2022 strain, though it remains primarily a contact-related infection.